Compare Nasdaq Inc (NDAQ) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs Summit Therapeutics Inc — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Nasdaq Inc is far larger — about 5× Summit Therapeutics Inc's market cap, and Nasdaq Inc pays a 1.22% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NDAQ | SMMT | |
|---|---|---|
Market Cap | $51.96B | $10.48B |
Sector | Financials | Health |
52-Week High | $100.98 | $29.32 |
52-Week Low | $76.85 | $13.05 |
Enterprise Value | $59.02B | $9.90B |
Dividend Yield | 1.22% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
